Pharmabiz1h
ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck
ModeX Therapeutics Inc., an OPKO Health company, announces dosing of the first participant in the phase I study (NCT06655324) of an Epstein-Barr virus (EBV) vaccine candidate being developed in ...
Pharmabiz1h
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Thursday, January 9, 2025, 17:20 Hrs [IST] Global pharma major Lupin Limited ...
Pharmabiz2h
BlackfinBio acquires Parkinson’s IP patent portfolio from OXB
BlackfinBio acquires Parkinson’s IP patent portfolio from OXB: Sheffield, UK Thursday, January 9, 2025, 17:00 Hrs [IST] BlackfinBio Ltd (BFB), a clinical stage gene therapy comp ...
Pharmabiz3h
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins: Shanghai Thursday, January 9, 2025, 1 ...
Pharmabiz3h
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams: Our Bureau, Bengaluru Thursday, January 9, 2025, 15:30 Hrs [IST] Eli Lilly an ...
Pharmabiz1d
MTaI to host MedTekon 2025 in New Delhi on January 30
Our Bureau, New Delhi Wednesday, January 8, 2025, 09:00 Hrs [IST] Medical Technology Association of India (MTaI), which repr ...
Pharmabiz4h
Sutro Biopharma & Boehringer Ingelheim BioXcellence collaboration: Established first-in-class cell-free capabilities at commercial scale
Ingelheim, Germany Thursday, January 9, 2025, 15:00 Hrs [IST] ...
Pharmabiz1d
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act: Shardul Nautiyal, Mumbai Wednesday, January 8, 2025, 08:00 Hrs [IST] Despit ...
Pharmabiz1d
TN DCA gearing up for inspection of pharma units to ensure compliance with revised Schedule M
Peethaambaran Kunnathoor, Chennai Wednesday, January 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz1d
Indian health sector navigating complexities of M&As: Harsh Vaish
Harsh Vaish: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] Mergers and Acquisitions (M&As) have ...
Pharmabiz4h
US FDA clears Solid Biosciences’ IND application for SGT-212 to treat neurologic & cardiac manifestations of Friedreich’s ataxia
Charlestown, Massachusetts Thursday, January 9, 2025, 14:30 Hrs [IST] ...
Pharmabiz1d
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...